Citation Formats
CD66b(+)monocytes represent a proinflammatory myeloid subpopulation in cancer
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

U. Horzum Et Al. , "CD66b(+)monocytes represent a proinflammatory myeloid subpopulation in cancer," CANCER IMMUNOLOGY IMMUNOTHERAPY , vol.70, no.1, pp.75-87, 2021

Horzum, U. Et Al. 2021. CD66b(+)monocytes represent a proinflammatory myeloid subpopulation in cancer. CANCER IMMUNOLOGY IMMUNOTHERAPY , vol.70, no.1 , 75-87.

Horzum, U., Yoyen-Ermis, D., Taskiran, E. Z., Yilmaz, K. B., HAMALOĞLU, E., KARAKOÇ, D., ... ESENDAĞLI, G.(2021). CD66b(+)monocytes represent a proinflammatory myeloid subpopulation in cancer. CANCER IMMUNOLOGY IMMUNOTHERAPY , vol.70, no.1, 75-87.

Horzum, Utku Et Al. "CD66b(+)monocytes represent a proinflammatory myeloid subpopulation in cancer," CANCER IMMUNOLOGY IMMUNOTHERAPY , vol.70, no.1, 75-87, 2021

Horzum, Utku Et Al. "CD66b(+)monocytes represent a proinflammatory myeloid subpopulation in cancer." CANCER IMMUNOLOGY IMMUNOTHERAPY , vol.70, no.1, pp.75-87, 2021

Horzum, U. Et Al. (2021) . "CD66b(+)monocytes represent a proinflammatory myeloid subpopulation in cancer." CANCER IMMUNOLOGY IMMUNOTHERAPY , vol.70, no.1, pp.75-87.

@article{article, author={Utku Horzum Et Al. }, title={CD66b(+)monocytes represent a proinflammatory myeloid subpopulation in cancer}, journal={CANCER IMMUNOLOGY IMMUNOTHERAPY}, year=2021, pages={75-87} }